X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-31-2024-59527.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207347
https://www.globenewswire.com/news-release/2023/02/22/2613155/12565/en/Alimera-Announces-Submission-of-Marketing-Authorization-Application-in-Switzerland-for-ILUVIEN.html
https://www.globenewswire.com/news-release/2022/10/06/2529457/12565/en/Paladin-Phase-4-Study-Confirms-ILUVIEN-Patients-Reduced-Need-for-Multiple-Treatments.html
https://www.globenewswire.com/news-release/2022/09/23/2521742/12565/en/Alimera-Announces-Agreement-with-Jaeb-Center-for-Health-Research-on-Behalf-of-the-DRCR-Retina-Network.html
https://www.globenewswire.com/news-release/2022/08/31/2507665/12565/en/Alimera-Announces-Multiple-Abstracts-Highlighting-ILUVIEN-Real-World-Data-at-EURETINA-Annual-Congress.html
https://www.hcplive.com/view/researchers-compare-intravitreal-implants-non-infectious-posterior-uveitis
https://www.globenewswire.com/news-release/2020/09/23/2097913/0/en/Alimera-Sciences-Announces-Multiple-Posters-and-Papers-Highlighting-the-Durability-of-ILUVIEN-To-Be-Presented-at-the-EURETINA-2020-Virtual-Congress.html
https://www.globenewswire.com/news-release/2020/09/01/2086857/0/en/Alimera-Sciences-Announces-Enrollment-of-First-Patient-in-Landmark-NEW-DAY-Clinical-Trial-to-Evaluate-ILUVIEN-as-Baseline-Therapy-for-Diabetic-Macular-Edema.html
http://investors.eyepointpharma.com/news-releases/news-release-details/eyepoint-pharmaceuticals-presents-data-supporting-yutiqr
https://www.globenewswire.com/news-release/2020/07/09/2059909/0/en/Alimera-Sciences-Initiates-Landmark-NEW-DAY-Clinical-Trial-to-Evaluate-ILUVIEN-as-Baseline-Therapy-for-Diabetic-Macular-Edema.html
https://endpts.com/building-on-successful-pd-1-pact-eli-lilly-licenses-diabetes-drug-to-chinese-partners-at-innovent/
https://www.biospectrumasia.com/news/30/14158/tga-approves-new-drug-for-diabetes-induced-vision-loss.html
https://www.pharmacompass.com/pdf/news/advanced-botanical-consulting-testing-inc-dba-abc-testing-receives-fda-warning-letter-1560416930.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209913
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211815
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210747
https://www.biospace.com/article/fda-action-alert-eyepoint-pharma-and-merck/
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-October-31-2018-1540974685.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210556
http://svt.com/en/laboratorios-salvat-completes-patient-recruitment-for-the-ciflotex-trial-2/
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-18-2018-1531894333.pdf
https://www.fiercepharma.com/marketing/plan-plan-and-plan-some-more-alimera-s-recipe-for-social-media-success-built-prep-work
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-2-2018-1525237297.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210736
https://endpts.com/novartis-backs-eye-drop-maker-in-20m-round-meds-to-fill-gap-left-by-eylea-lucentis/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209596
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202849
http://www.prnewswire.com/news-releases/perrigo-announces-the-launch-of-generic-equivalents-to-derma-smoothefs-scalp-oil-and-body-oil-300477463.html
http://svt.com/en/pediapharm-announces-the-commercial-launch-of-otixal-in-canada/
https://www.pharmacompass.com/pdf/news/actaviss-generic-fluocinolone-acetonide-approved-in-us-1477391054.pdf
https://www.pharmacompass.com/pdf/news/versapharms-generic-fluocinolone-acetonide-approved-in-us-1473844929.pdf
http://www.prnewswire.com/news-releases/laboratorios-salvat-sa-and-arbor-pharmaceuticals-llc-announce-the-launch-of-otovel-ciprofloxacin-03--and-fluocinolone-acetonide-0025--otic-solution-300319434.html
https://www.pharmacompass.com/pdf/news/taros-generic-fluocinolone-acetonide-approved-in-us-to-reduce-skin-inflammation-1464092165.pdf
https://www.pharmacompass.com/pdf/news/laboratorios-salvats-otovel-ciprofloxacinfluocinolone-acetonide-approved-in-us-for-bacterial-infections-1462268989.pdf
http://www.prnewswire.com/news-releases/salvat-and-lees-pharmaceutical-hk-limited-announce-exclusive-license-and-supply-agreement-for-duoxal-in-greater-china-564981691.html
http://www.prnewswire.com/news-releases/alimera-sciences-signs-agreement-to-distribute-iluvien-in-the-middle-east-300192823.html
http://www.prnewswire.com/news-releases/alimera-sciences-announces-late-breaking-presentation-of-new-iluvien-analysis-during-retina-subspecialty-day-at-aao-annual-meeting-2015-300170110.html
https://www.pharmacompass.com/pdf/news/gavis-generic-fluocinolone-acetonide-001-approved-in-us-for-skin-inflammation-1441626001.pdf
http://psdv.client.shareholder.com/releasedetail.cfm?ReleaseID=906413
http://www.raps.org/Regulatory-Focus/News/2015/03/09/21677/FDA-Provides-Generic-Approval-Roadmap-for-38-Drugs-Including-Vertexs-Kaldeco/
http://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=892888
http://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=891326
Market Place
Share 
